Provided by Tiger Trade Technology Pte. Ltd.

Apimeds Pharmaceutical U.S, Inc.

4.84
+0.450010.25%
Post-market: 5.070.2328+4.81%19:59 EDT
Volume:559.53K
Turnover:2.65M
Market Cap:7.30M
PE:-0.13
High:5.43
Open:4.30
Low:4.18
Close:4.39
52wk High:59.70
52wk Low:3.39
Shares:1.51M
Float Shares:304.73K
Volume Ratio:1.63
T/O Rate:183.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-38.5450
EPS(LYR):-0.1759
ROE:-144.99%
ROA:-69.29%
PB:0.90
PE(LYR):-27.52

Loading ...

Company Profile

Company Name:
Apimeds Pharmaceutical U.S, Inc.
Exchange:
AMEX
Establishment Date:
2020
Employees:
- -
Office Location:
100 Matawan Rd,Suite 325,Matawan,New Jersey,United States
Zip Code:
07747
Fax:
- -
Introduction:
Apimeds Pharmaceuticals US, Inc. was incorporated in Delaware on May 11, 2020. They are a clinical-stage biopharmaceutical company developing Apitox, an intradermal injectable bee venom toxin. Their primary focus is on developing innovative therapies to address inflammation and pain management symptoms associated with knee osteoarthritis (OA).

Directors

Name
Position
Bennett Weintraub
Director
Carol O'Donnell
Director
Elona Kogan
Director

Shareholders

Name
Position
Vin Menon
Chief Executive Officer
Erick Frim
Chief Financial Officer
Christopher Kim
Chief Medical Officer